phase readout
saveNCT07439055: Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric Hemophilia A
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Chulalongkorn University. Phase: PHASE2. Conditions: Hemophilia A Patient
view source ↗
comments(0)
5-min edit window · permanent after that